153
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Psychotropic Drug Use in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS): A Danish Nationwide Matched Cohort Study of 2404 AML and 1307 MDS Patients

, ORCID Icon, , , , , , , , , , & ORCID Icon show all
Pages 225-237 | Published online: 25 Feb 2022

References

  • Deschler B, Lübbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer. 2006;107(9):2099–2107. doi:10.1002/cncr.22233
  • Ding T, Wang X, Fu A, Xu L, Lin J. Anxiety and depression predict unfavorable survival in acute myeloid leukemia patients. Med (United States). 2019;98(43):1–7.
  • Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136–1152. doi:10.1056/NEJMra1406184
  • El-Jawahri A, Abel GA, Traeger L, et al. Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy. Leukemia. 2019;33:2393–2402. doi:10.1038/s41375-019-0449-1
  • Østgård LSG, Nørgaard JM, Raaschou-Jensen KK, et al. The Danish national acute leukemia registry. Clin Epidemiol. 2016;8:553–560. doi:10.2147/CLEP.S99460
  • Dan C, Chi J, Wang L. Molecular mechanisms of the progression of myelodysplastic syndrome to secondary acute myeloid leukaemia and implication for therapy. Ann Med. 2015;47(3):209–217. doi:10.3109/07853890.2015.1009156
  • Besson C, Rannou S, Elmaaroufi H, et al. Disclosure of myelodysplastic syndrome diagnosis: improving patients’ understanding and experience. Eur J Haematol. 2013;90(2):151–156. doi:10.1111/ejh.12048
  • Sekeres MA, Maciejewski JP, List AF, et al. Perceptions of disease state, treatment outcomes, and prognosis among patients with myelodysplastic syndromes: results from an internet‐based survey. Oncologist. 2011;16(6):904–911. doi:10.1634/theoncologist.2010-0199
  • Group TDAL. Annual leukemia report 2019 [in Danish]. Aarhus, Denmark; 2019.
  • Steensma DP. Myelodysplastic syndromes current treatment algorithm 2018. Blood Cancer J. 2018;8(5):47. doi:10.1038/s41408-018-0085-4
  • Montalban-Bravo G, Garcia-Manero G. Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management. Am J Hematol. 2018;93(1):129–147. doi:10.1002/ajh.24930
  • Linden W, Vodermaier A, MacKenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141(2–3):343–351. doi:10.1016/j.jad.2012.03.025
  • Gheihman G, Zimmermann C, Deckert A, et al. Depression and hopelessness in patients with acute leukemia: the psychological impact of an acute and life-threatening disorder. Psychooncology. 2016;989:979–989. doi:10.1002/pon.3940
  • Ng CG, Boks MP, Smeets HM, Zainal NZ, De Wit NJ. Prescription patterns for psychotropic drugs in cancer patients; A large population study in the Netherlands. Psychooncology. 2013;22(4):762–767. doi:10.1002/pon.3056
  • Ng CG, Boks MPM, Zainal NZ, De Wit NJ. The prevalence and pharmacotherapy of depression in cancer patients. J Affect Disord. 2011;131(1–3):1–7. doi:10.1016/j.jad.2010.07.034
  • Jacob L, Kostev K, Kalder M. Treatment of depression in cancer and non-cancer patients in German neuropsychiatric practices. Psychooncology. 2016;25(11):1324–1328. doi:10.1002/pon.4066
  • Øvlisen AK, Jakobsen LH, Kragholm KH, et al. Depression and anxiety in Hodgkin lymphoma patients: a Danish nationwide cohort study of 945 patients. Cancer Med. 2020;9(12):4395–4404. doi:10.1002/cam4.2981
  • Hinz A, Krauss O, Hauss JP, et al. Anxiety and depression in cancer patients compared with the general population. Eur J Cancer Care (Engl). 2010;19(4):522–529. doi:10.1111/j.1365-2354.2009.01088.x
  • Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychol Med. 2010;40(11):1797–1810. doi:10.1017/S0033291709992285
  • Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-3
  • Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39(7):22–25. doi:10.1177/1403494810387965
  • Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011;39(7):91–94. doi:10.1177/1403494810394715
  • Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. Dove Medical Press Ltd. doi:10.2147/CLEP.S91125
  • Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11(1):83. doi:10.1186/1471-2288-11-83
  • Pottegård A, Schmidt SAJ, Wallach-Kildemoes H, Sørensen HT, Hallas J, Schmidt M. Data resource profile: the Danish national prescription registry. Int J Epidemiol. 2017;46(3):798. doi:10.1093/ije/dyw213
  • Wallach Kildemoes H, Toft Sørensen H, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7_suppl):38–41. doi:10.1177/1403494810394717
  • Granfeldt Østgård LS, Nørgaard JM, Severinsen MT, et al. Data quality in the Danish National acute Leukemia Registry: a hematological data resource. Clin Epidemiol. 2013;5(1):335–344. doi:10.2147/CLEP.S48411
  • Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16(3). doi:10.1214/aos/1176350951
  • Juliusson G, Antunovic P, Derolf Å, et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood. 2009;113(18):4179–4187. doi:10.1182/blood-2008-07-172007
  • Sundhedsstyrelsen. Referenceprogram for unipolar depression hos voksne. [Internet]; [ cited December 22, 2020]. Available from: http://sst.dk. Accessed January 20, 2022.
  • Sundhedsstyrelsen. National klinisk retningslinje for non-farmakologisk behandling af unipolar depression. [Internet]; [ cited December 22, 2020]. Available from: http://sst.dk. Accessed January 20, 2022.
  • Peterson LG, Leipman M, Bongar B. Psychotropic medications in patients with cancer. Gen Hosp Psychiatry. 1987;9(5):313–323. doi:10.1016/0163-8343(87)90062-4
  • Lynch ME. Antidepressants as analgesics: a review of randomized controlled trials. J Psychiatry Neurosci. 2001;26(1):30.
  • Skånland SS, Cieślar-Pobuda A. Off-label uses of drugs for depression. Eur J Pharmacol. 2019;865:172732. doi:10.1016/j.ejphar.2019.172732
  • Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160–174. doi:10.1016/S1470-2045(11)70002-X
  • Esser P, Hartung TJ, Friedrich M, et al. The Generalized Anxiety Disorder Screener (GAD-7) and the anxiety module of the Hospital and Depression Scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients. Psychooncology. 2018;27(6):1509–1516. doi:10.1002/pon.4681
  • Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst. 2009;101:1464–1488. doi:10.1093/jnci/djp336